UK Grants Approval To Pfizer And AstraZeneca For COVID Booster Jabs
The MHRA further stated that the Joint Committee on Vaccination and Immunisation (JCVI), the UK's vaccine advisory authority will be consulted to determine if booster shots will be given and if yes, then which vaccines should be used.
Pfizer and AstraZeneca vaccines for COVID-19 booster doses have been approved by the UK health agency despite the country's decision on the third dose still pending.
In a statement released on Thursday, June Raine, Chief Executive of Medicines and Healthcare products Regulatory Agency (MHRA) said, “We know that a person's immunity may decline over time after their first vaccine course. I am pleased to confirm that the COVID-19 vaccines made by Pfizer and AstraZeneca can be used as safe and effective booster doses.”
The MHRA and the independent Commission on Human Medicines (CHM), which advises the government, have also decided to conduct a thorough examination of the current data based on the safety and effectiveness of booster vaccine doses.
The MHRA further stated that the Joint Committee on Vaccination and Immunisation (JCVI), the UK's vaccine advisory authority will be consulted to determine if booster shots will be given and if yes, then which vaccines should be used. Although JCVI has said, people with highly compromised immune systems in the UK, should receive a third dosage of the vaccine.
Pascal Soriot, CEO of AstraZeneca, cautioned against rushing towards a statewide implementation, warning that it could put further strain on the already overburdened National Health Service (NHS) in the United Kingdom. On the other hand, according to Pfizer's CEO Albert Bourla, a third dosage of Covid vaccination is likely to be required between six and twelve months after the initial jab.
People with immunodeficiency have already begun receiving a third dose in the United States. Also countries like Israel, Russia, France and Italy have already started implementing booster vaccines.